Profil
Spencer W.
Farr is the founder of Vista Therapeutics, Inc. where he holds the title of President.
Dr. Farr is also the founder of Xenometrix, Inc., Molecular Toxicology, Inc...
.
Dr. Farr is also the founder of Xenometrix, Inc., Molecular Toxicology, Inc...
Aktive Positionen von Spencer W. Farr
| Unternehmen | Position | Beginn |
|---|---|---|
Vista Therapeutics, Inc.
 Vista Therapeutics, Inc. BiotechnologyHealth Technology Vista Therapeutics, Inc. develops nanotechnology for multiplex biomarker measurement. Its NanoBioSensor technology provides continuous, real-time measurement of multiple biomarkers simultaneously in any clinical setting. The firm's technology can be used to improve the quality of animal data in drug development. The company was founded by Spencer W. Farr and Charles M. Lieber in 2007 and is headquartered in Santa Fe, NM. | Gründer | 01.01.2007 |
Ehemalige bekannte Positionen von Spencer W. Farr
| Unternehmen | Position | Ende |
|---|---|---|
| Molecular Toxicology, Inc. | Vorstandsvorsitzender | - |
Xenometrix, Inc.
 Xenometrix, Inc. Medical SpecialtiesHealth Technology Xenometrix, Inc. operates as a biotechnology company with a proprietary gene profiling system that characterizes a cell's response when tested with compounds and other agents by the pattern of genes turned on and off in the cell. The company was founded by Spencer Farr and is headquartered in Boulder, CO. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Xenometrix, Inc.
Xenometrix, Inc. Medical SpecialtiesHealth Technology Xenometrix, Inc. operates as a biotechnology company with a proprietary gene profiling system that characterizes a cell's response when tested with compounds and other agents by the pattern of genes turned on and off in the cell. The company was founded by Spencer Farr and is headquartered in Boulder, CO. | Health Technology |
Vista Therapeutics, Inc.
Vista Therapeutics, Inc. BiotechnologyHealth Technology Vista Therapeutics, Inc. develops nanotechnology for multiplex biomarker measurement. Its NanoBioSensor technology provides continuous, real-time measurement of multiple biomarkers simultaneously in any clinical setting. The firm's technology can be used to improve the quality of animal data in drug development. The company was founded by Spencer W. Farr and Charles M. Lieber in 2007 and is headquartered in Santa Fe, NM. | Health Technology |
| Molecular Toxicology, Inc. |
